Annexon (ANNX) Change in Accured Expenses (2019 - 2026)

Annexon's (ANNX) quarterly Change in Accured Expenses came in at -$9.4 million in Q1 2026, down 421.22% year-on-year from $2.9 million in Q1 2025, and down 517.73% quarter-over-quarter from $2.2 million in Q4 2025.

Annexon (ANNX) Change in Accured Expenses (2019 - 2026) Analysis & Trends

Annexon's Change in Accured Expenses history runs 8 years deep, the most recent figure standing at -$9.4 million for Q1 2026.

  • On a quarterly basis, Change in Accured Expenses fell 421.22% year-over-year to -$9.4 million in Q1 2026; TTM through Mar 2026 was -$5.1 million, a 137.55% decrease from a year earlier, with the FY2025 full-year figure at $7.2 million, down 0.95% from the prior year.
  • Change in Accured Expenses slipped to -$9.4 million in Q1 2026 per ANNX's latest filing, from $2.2 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $6.7 million in Q4 2024 and bottomed at -$9.4 million in Q1 2026.
  • The 5-year median for Change in Accured Expenses is $10000.0 (2022), against an average of $92941.2.
  • Biggest YoY gain for Change in Accured Expenses was 25350.0% in 2023; the steepest drop was 6796.0% in 2023.
  • Year by year, Change in Accured Expenses stood at $10000.0 in 2022, then tumbled by 6190.0% to -$609000.0 in 2023, then jumped by 1201.31% to $6.7 million in 2024, then slumped by 66.45% to $2.2 million in 2025, then tumbled by 517.73% to -$9.4 million in 2026.
  • Per Business Quant, the three latest ANNX Change in Accured Expenses figures stand at -$9.4 million (Q1 2026), $2.2 million (Q4 2025), and -$3.9 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 1.13 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -16.82 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 23.10 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 107.70 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -16.74 Mn
10 Annexon 1.03 Bn 804.24 Mn - -9.40 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -9.40 Mn
Mar 31, 2026 -9.40 Mn
Dec 31, 2025 2.25 Mn
Dec 31, 2025 2.25 Mn
Sep 30, 2025 -3.87 Mn
Sep 30, 2025 -3.87 Mn
Jun 30, 2025 5.92 Mn
Jun 30, 2025 5.92 Mn
Mar 31, 2025 2.93 Mn
Mar 31, 2025 2.93 Mn
Dec 31, 2024 6.71 Mn
Dec 31, 2024 6.71 Mn
Sep 30, 2024 412,000.00
Sep 30, 2024 412,000.00
Jun 30, 2024 3.54 Mn
Jun 30, 2024 3.54 Mn
Mar 31, 2024 -3.37 Mn
Mar 31, 2024 -3.37 Mn
Dec 31, 2023 -609,000.00
Dec 31, 2023 -609,000.00